0001759425-18-000001.txt : 20181120 0001759425-18-000001.hdr.sgml : 20181120 20181120154957 ACCESSION NUMBER: 0001759425-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181120 DATE AS OF CHANGE: 20181120 EFFECTIVENESS DATE: 20181120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326260 FILM NUMBER: 181195573 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 619-733-3852 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0708 D LIVE 0001759425 Mirum Pharmaceuticals, Inc. 12230 EL CAMINO REAL, SUITE 230 SAN DIEGO CA CALIFORNIA 92130 619-733-3852 DELAWARE None None Corporation true 2018 Michael Grey c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Executive Officer Director Susan Dube c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Executive Officer Ed Mathers c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Patrick Heron c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Jonathan Leff c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Tiba Aynechi c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Chris Peetz c/o Mirum Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA CALIFORNIA 92130 Director Pharmaceuticals Decline to Disclose 06b false 2018-11-05 false true false 0 120063750 60063750 60000000 Includes amounts paid both in cash and pursuant to automatic conversion of indebtedness. false 14 0 0 0 false Mirum Pharmaceuticals, Inc. /s/ Susan Dube Susan Dube Chief Financial Officer 2018-11-19